VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,700 | -97.3% | 10,000 | -92.8% | 0.05% | -97.2% |
| Q2 2023 | $3,424,388 | +137.4% | 139,600 | +125.2% | 1.81% | +104.9% |
| Q1 2023 | $1,442,740 | +137.5% | 62,000 | +158.3% | 0.88% | +114.8% |
| Q4 2022 | $607,440 | -27.4% | 24,000 | +20.0% | 0.41% | +21.2% |
| Q4 2021 | $837,000 | -31.3% | 20,000 | -28.6% | 0.34% | -37.0% |
| Q3 2021 | $1,219,000 | +113.5% | 28,000 | +132.0% | 0.54% | +166.3% |
| Q2 2021 | $571,000 | +54.7% | 12,071 | +67.8% | 0.20% | +26.2% |
| Q1 2021 | $369,000 | -34.3% | 7,192 | -65.8% | 0.16% | -31.0% |
| Q4 2020 | $562,000 | -37.1% | 21,000 | -19.2% | 0.23% | -49.2% |
| Q3 2020 | $893,000 | +190.9% | 26,000 | +246.7% | 0.46% | +165.7% |
| Q2 2020 | $307,000 | – | 7,500 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |